Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7621 USD | -0.41% |
|
-5.73% | -31.34% |
05-31 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-15 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- MarketScreener Strategies